RhumbLine Advisers’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-1,724
| Closed | -$86K | – | 3296 |
|
2022
Q1 | $86K | Buy |
1,724
+228
| +15% | +$11.4K | ﹤0.01% | 2916 |
|
2021
Q4 | $113K | Hold |
1,496
| – | – | ﹤0.01% | 2927 |
|
2021
Q3 | $118K | Buy |
1,496
+40
| +3% | +$3.16K | ﹤0.01% | 2978 |
|
2021
Q2 | $202K | Buy |
1,456
+422
| +41% | +$58.5K | ﹤0.01% | 2922 |
|
2021
Q1 | $216K | Buy |
+1,034
| New | +$216K | ﹤0.01% | 2813 |
|
2020
Q3 | – | Sell |
-1,016
| Closed | -$169K | – | 3053 |
|
2020
Q2 | $169K | Buy |
+1,016
| New | +$169K | ﹤0.01% | 2830 |
|